Home LiteratureArticle Details
PMID: 16923753 Published · ppublish English Comparative Study Journal Article Research Support, N.I.H., Extramural Research Support, U.S. Gov't, Non-P.H.S.

Specific temporal profile of matrix metalloproteinase release occurs in patients after myocardial infarction: relation to left ventricular remodeling.

Circulation ·Vol. 114 ·No. 10 ·2006-09-05 ·Pages 1020-7

Webb CS, Bonnema DD, Ahmed SH, Leonardi AH, McClure CD, Clark LL, Stroud RE, Corn WC, Finklea L, Zile MR, Spinale FG

Abstract

Changes in matrix metalloproteinase (MMP) and tissue inhibitors of MMPs (TIMPs) contribute to left ventricular (LV) remodeling after myocardial infarction (MI). We tested the hypothesis that a specific plasma MMP/TIMP profile would emerge after MI and be associated with the degree of LV dilation. LV end-diastolic volume and MMP/TIMP plasma profiles were determined in 53 age-matched control subjects and 32 post-MI patients from day 1 through 180 after MI. LV end-diastolic volume increased by > 38% at day 90 after MI (P < 0.05). MMP-9 increased by > 150% from control at day 1 after MI (P < 0.05) and remained elevated. MMP-8 rose to > 120% at day 3 after MI (P < 0.05) and fell to control values by day 5. TIMP-1 increased by > 60% from control at day 1 after MI (P < 0.05), whereas TIMP-2 increased only at later time points. Cardiac-specific TIMP-4 fell by 40% at day 5 after MI and remained reduced. A persistent or elevated MMP-9 at day 5 was accompanied by a 3-fold end-diastolic volume increase at day 28 (P < 0.05). A specific temporal pattern of MMP/TIMPs occurred in post-MI patients that included an early and robust rise in MMP-9 and MMP-8 and a uniform fall in TIMP-4. These findings suggest that a specific MMP/TIMP plasma profile occurs after MI and holds both prognostic and diagnostic significance.

MeSH Terms
Biomarkers/blood Electrocardiography Female Gelatinases/blood Humans Male Matrix Metalloproteinases/blood Middle Aged Myocardial Infarction/blood,drug therapy,enzymology Reference Values Thrombolytic Therapy Tissue Inhibitor of Metalloproteinase-1/blood Tissue Inhibitor of Metalloproteinase-2/blood Ventricular Remodeling/physiology
Chemicals
Biomarkers Tissue Inhibitor of Metalloproteinase-1 Tissue Inhibitor of Metalloproteinase-2 Gelatinases Matrix Metalloproteinases
Authors & Affiliations
11 authors, click to expand affiliations / ORCID
Webb Carson S
Division of Cardiology, Department of Medicine, Medical University of South Carolina, Charleston, SC 29425, USA.
Bonnema David D
Ahmed S Hinan
Leonardi Amy H
McClure Catherine D
Clark Leslie L
Stroud Robert E
Corn William C
Finklea Laura
Zile Michael R
Spinale Francis G
Article Info
Journal
Circulation
Abbr.
Circulation
ISSN
1524-4539
Published
2006-09-05
Epub
2006-00-21
Pages
1020-7
Language
English
Region
United States
NLM ID
0147763
Subset
IM
Grants
NCRR NIH HHS · MO1-RR-01070-251 · United States
NHLBI NIH HHS · P01-HL-48788 · United States
NHLBI NIH HHS · R01-HL-59165 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com